109 related articles for article (PubMed ID: 19207106)
1. Characterization of the catalytic activity of the membrane-anchored metalloproteinase ADAM15 in cell-based assays.
Maretzky T; Yang G; Ouerfelli O; Overall CM; Worpenberg S; Hassiepen U; Eder J; Blobel CP
Biochem J; 2009 Apr; 420(1):105-13. PubMed ID: 19207106
[TBL] [Abstract][Full Text] [Related]
2. The role of the disintegrin metalloproteinase ADAM15 in prostate cancer progression.
Lucas N; Day ML
J Cell Biochem; 2009 Apr; 106(6):967-74. PubMed ID: 19229865
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the catalytic properties of the membrane-anchored metalloproteinase ADAM9 in cell-based assays.
Maretzky T; Swendeman S; Mogollon E; Weskamp G; Sahin U; Reiss K; Blobel CP
Biochem J; 2017 Apr; 474(9):1467-1479. PubMed ID: 28264989
[TBL] [Abstract][Full Text] [Related]
4. Characterization of oxygen-induced retinopathy in mice carrying an inactivating point mutation in the catalytic site of ADAM15.
Maretzky T; Blobel CP; Guaiquil V
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6774-82. PubMed ID: 25249606
[TBL] [Abstract][Full Text] [Related]
5. Homeostatic effects of the metalloproteinase disintegrin ADAM15 in degenerative cartilage remodeling.
Böhm BB; Aigner T; Roy B; Brodie TA; Blobel CP; Burkhardt H
Arthritis Rheum; 2005 Apr; 52(4):1100-9. PubMed ID: 15818704
[TBL] [Abstract][Full Text] [Related]
6. ADAM15 suppresses cell motility by driving integrin alpha5beta1 cell surface expression via Erk inactivation.
Chen Q; Meng LH; Zhu CH; Lin LP; Lu H; Ding J
Int J Biochem Cell Biol; 2008; 40(10):2164-73. PubMed ID: 18387333
[TBL] [Abstract][Full Text] [Related]
7. Presence, processing, and localization of mouse ADAM15 during sperm maturation and the role of its disintegrin domain during sperm-egg binding.
Pastén-Hidalgo K; Hernández-Rivas R; Roa-Espitia AL; Sánchez-Gutiérrez M; Martínez-Pérez F; Monrroy AO; Hernández-González EO; Mújica A
Reproduction; 2008 Jul; 136(1):41-51. PubMed ID: 18390692
[TBL] [Abstract][Full Text] [Related]
8. Critical function for ADAM9 in mouse prostate cancer.
Peduto L; Reuter VE; Shaffer DR; Scher HI; Blobel CP
Cancer Res; 2005 Oct; 65(20):9312-9. PubMed ID: 16230393
[TBL] [Abstract][Full Text] [Related]
9. Fluorescent substrates for ADAM15 useful for assaying and high throughput screening.
Moss ML; Miller MA; Vujanovic N; Yoneyama T; Rasmussen FH
Anal Biochem; 2016 Dec; 514():42-47. PubMed ID: 27637923
[TBL] [Abstract][Full Text] [Related]
10. Exosome release of ADAM15 and the functional implications of human macrophage-derived ADAM15 exosomes.
Lee HD; Koo BH; Kim YH; Jeon OH; Kim DS
FASEB J; 2012 Jul; 26(7):3084-95. PubMed ID: 22505472
[TBL] [Abstract][Full Text] [Related]
11. Screening cellular proteins involved in the anti-proliferative effect of the ADAM15 disintegrin domain in murine melanoma cells.
Wu J; Zhang L; Ma X; Zhang X; Jin J
Oncol Rep; 2008 Sep; 20(3):669-75. PubMed ID: 18695922
[TBL] [Abstract][Full Text] [Related]
12. LPS activates ADAM9 dependent shedding of ACE from endothelial cells.
English WR; Corvol P; Murphy G
Biochem Biophys Res Commun; 2012 Apr; 421(1):70-5. PubMed ID: 22480688
[TBL] [Abstract][Full Text] [Related]
13. Src stimulates fibroblast growth factor receptor-2 shedding by an ADAM15 splice variant linked to breast cancer.
Maretzky T; Le Gall SM; Worpenberg-Pietruk S; Eder J; Overall CM; Huang XY; Poghosyan Z; Edwards DR; Blobel CP
Cancer Res; 2009 Jun; 69(11):4573-6. PubMed ID: 19487280
[TBL] [Abstract][Full Text] [Related]
14. ADAM15 expression is downregulated in melanoma metastasis compared to primary melanoma.
Ungerer C; Doberstein K; Bürger C; Hardt K; Boehncke WH; Böhm B; Pfeilschifter J; Dummer R; Mihic-Probst D; Gutwein P
Biochem Biophys Res Commun; 2010 Oct; 401(3):363-9. PubMed ID: 20851104
[TBL] [Abstract][Full Text] [Related]
15. ADAM15 mediates upregulation of Claudin-1 expression in breast cancer cells.
Mattern J; Roghi CS; Hurtz M; Knäuper V; Edwards DR; Poghosyan Z
Sci Rep; 2019 Aug; 9(1):12540. PubMed ID: 31467400
[TBL] [Abstract][Full Text] [Related]
16. A disintegrin and metalloproteinase 15-mediated glycocalyx shedding contributes to vascular leakage during inflammation.
Yang X; Meegan JE; Jannaway M; Coleman DC; Yuan SY
Cardiovasc Res; 2018 Nov; 114(13):1752-1763. PubMed ID: 29939250
[TBL] [Abstract][Full Text] [Related]
17. ADAM15 Is Functionally Associated with the Metastatic Progression of Human Bladder Cancer.
Lorenzatti Hiles G; Bucheit A; Rubin JR; Hayward A; Cates AL; Day KC; El-Sawy L; Kunju LP; Daignault S; Lee CT; Liebert M; Hussain M; Day ML
PLoS One; 2016; 11(3):e0150138. PubMed ID: 26930657
[TBL] [Abstract][Full Text] [Related]
18. Meltrin beta (ADAM19) mediates ectodomain shedding of Neuregulin beta1 in the Golgi apparatus: fluorescence correlation spectroscopic observation of the dynamics of ectodomain shedding in living cells.
Yokozeki T; Wakatsuki S; Hatsuzawa K; Black RA; Wada I; Sehara-Fujisawa A
Genes Cells; 2007 Mar; 12(3):329-43. PubMed ID: 17352738
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the microenvironment and adhesion of cancer cells by ADAMs (a disintegrin and metalloproteinase).
Okada Y
Verh Dtsch Ges Pathol; 2007; 91():29-38. PubMed ID: 18314593
[TBL] [Abstract][Full Text] [Related]
20. The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation.
Najy AJ; Day KC; Day ML
J Biol Chem; 2008 Jun; 283(26):18393-401. PubMed ID: 18434311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
